Option delistings effective August 18th include Q32 Bio Inc (QTTB), Hyperdynamics Corp (HYPD), Bionano Genomics (BNGO), Allurion Technologies Inc (ALUR), Moxian (BVI) Inc (ABTS), Spi Energy Co Ltd (SPIEF), TVARDI THERAPEUTICS INC (TVRD), and ZK International Group Ltd (ZKIN).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
- Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
- Q32 Bio Appoints New Interim Chief Medical Officer
- Q32 Bio chief medical officer Jason Campagna to depart
- Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary